Pulmonary vascular disease & thromboembolism

Differential effects of balloon pulmonary angioplasty on chronic thromboembolic pulmonary disease

HeartPublished Retrospective cohort study

Authors' conclusion

BPA was associated with an improvement in the haemodynamic status and exercise tolerance in patients with CTEPH even with low DLco. However, low DLco may attenuate the effect of BPA on mPAP and pulmonary vascular resistance and require more treatment sessions.

Study context

Population
Patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH) who underwent balloon pulmonary angioplasty (BPA) at the University of Tokyo Hospital, July 2011 to August 2023
Participants
75 patients
Exposure
Low DLco vs normal DLco in patients undergoing BPA
  • Low DLco (LD)n = 36
Outcome
mPAP after BPA
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Sβ

−0.304

95% CI −7.015 to −1.132P = 0.007

Mean pulmonary artery pressure (mPAP); ANCOVA adjusted for baseline values

Sβ

−0.324

95% CI −141.0 to −29.81P = 0.003

pulmonary vascular resistance; ANCOVA adjusted for baseline values

Observational data: associations, not effects.

Further findings

Baseline 6-minute walking distance (before BPA)

Baseline mPAP (before BPA)

Median

OutcomeNDLD
Number of BPA sessions46

Baseline mPAP (before BPA)

Baseline mPAP similar

Original publication

Differential effects of balloon pulmonary angioplasty on chronic thromboembolic pulmonary disease. Heart. Published 31 July 2024. doi:10.1136/heartjnl-2024-323883

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.